The global 3D Cell Culture market is forecasted to grow at high rate due to growing government funding and grant for research and development, rise in prevalence of cancer diseases, growth in technological advances and innovative research procedure. The Global 3D Cell Culture Market was valued at US$ 1,605.4 Mn in 2020 is expected to reach US$ 3,323.3 Mn by 2027, with a growing CAGR of 11.2% during the forecast period (2021-2027).
3D cell culture is a process of developing cells in artificially created environment. Cells are allowed to grow in three dimensions. This technique is most widely used in multicellular research or research associated with cellular mass such as cancer, drug toxicology screening and gene expression. Cells grown in 3D environment are similar in behaviour and characteristics of cells grown in in living organism. This is widely use in research and development. These cells grown mimics the human body cells and show same physiology and traits.
Various factors such as growth in launch of new products and advanced 3D protocols for biological research, increase in government funding, rise in collaboration of industries with research and academic centers, demand for personalized medicines and surge for the development of more sensitive research procedures with less wastage of materials drives the growth of 3D cell culture market.
3D cell culture market is broadly segmented into product type, application, end user and region. Based on product type, scaffold-based platform held maximum market share in 2020 about 70% and expected to increase during forecast period. The use of scaffold in 3D cell culture research helps in incorporation of heavy molecules, biochemical and mechanical signs in the matrix. This provides strong support to the culture.
Based in application, cancer segment dominate the market with the highest market share in 2020. This help in development of anticancer therapies during the forecast period. Further, the use of 3D cell culture in the study of cancer preclinical studies anticipate the highest revenue generation in this segment. Based on the end user, pharmaceutical and biotechnological industries segment accounted the highest market share in 2020 and expected to increase during the forecast period. This is due to increase in research activities such as pharmacogenomics, screening of drug molecules and genetically associated diseases globally. Geographically, North America accounted the highest market shares as compared to other regions due to growth in R&D infrastructure and funding for the development of therapies drives the growth of market in this region.
Global 3D Cell Culture Market by Region Outlook (Revenue, USD Million, 2021-2027)
Based on the region, North America accounted maximum market share in 2020 due to increase in government funding and grants for research and development in this region. With the increase in prevalence diseases such as cancer and infectious diseases, growing in number of collaborations of pharmaceutical and biotechnological companies with academic & research institute increases the demand for 3D Cell culture.
However, Europe is the second largest region that contributed the highest in market growth of 3D Cell culture market in 2020. This is due to increase in commercialization of innovative techniques like microfluid-based products and growing number of research centers drives the growth of market in this region.
The Global 3D Cell Culture Segmentation:
Global 3D Cell Culture Market by Product Outlook (Revenue, USD Million, 2021-2027)
Global 3D Cell Culture Market by Application Outlook (Revenue, USD Million, 2021-2027)
Global 3D Cell Culture Market by End User Outlook (Revenue, USD Million, 2021-2027)
Company Profiles and Competitive Intelligence
The key players operating in the market are: